2022
DOI: 10.1016/j.wneu.2022.03.077
|View full text |Cite
|
Sign up to set email alerts
|

The Quadrangular Space, Endonasal Access to the Meckel Cave: Technical Considerations and Clinical Series

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 24 publications
0
4
0
Order By: Relevance
“…And obviously, not all these cases can eventually be considered good candidates for a TOA. Indeed, if we change perspective and check current existing medical literature, our doubts are confirmed (31, [43][44][45][46][47][48][49]. Case series on SOM are normally collected over decades and seldom include more than 50 patients.…”
Section: Ftoz and Variationsmentioning
confidence: 99%
“…And obviously, not all these cases can eventually be considered good candidates for a TOA. Indeed, if we change perspective and check current existing medical literature, our doubts are confirmed (31, [43][44][45][46][47][48][49]. Case series on SOM are normally collected over decades and seldom include more than 50 patients.…”
Section: Ftoz and Variationsmentioning
confidence: 99%
“…3 Anatomical relationships of the lesion with surrounding neurovascular structures and surgeon's experience frequently influence the choice for surgical access. 4 Minimally invasive approaches may be applied in selected cases with dual or multiport corridors.…”
Section: Introductionmentioning
confidence: 99%
“…3,4 The endoscopic endonasal transpterygoid approach provides a safe entry to Meckel's cave through the quadrangular space, bounded by the petrous and paraclival internal carotid artery, the sixth cranial nerve, and the maxillary nerve. [4][5][6] This anteromedial trajectory allows a direct ventral access to this region, avoiding temporal lobe retraction. Extended variants of this approach may also be used to remove lesions in the pterygopalatine, infratemporal, and middle fossae, offering a wide range of exposure for these heterogenous tumors.…”
mentioning
confidence: 99%